BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27108265)

  • 1. Pay attention to cardiac remodeling in cancer cachexia.
    Zheng Y; Chen H; Li X; Sun Y
    Support Care Cancer; 2016 Jul; 24(7):3253-9. PubMed ID: 27108265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review).
    Belloum Y; Rannou-Bekono F; Favier FB
    Oncol Rep; 2017 May; 37(5):2543-2552. PubMed ID: 28393216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
    Springer J; Tschirner A; Haghikia A; von Haehling S; Lal H; Grzesiak A; Kaschina E; Palus S; Pötsch M; von Websky K; Hocher B; Latouche C; Jaisser F; Morawietz L; Coats AJ; Beadle J; Argiles JM; Thum T; Földes G; Doehner W; Hilfiker-Kleiner D; Force T; Anker SD
    Eur Heart J; 2014 Apr; 35(14):932-41. PubMed ID: 23990596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
    Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
    Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac alterations in cancer-induced cachexia in mice.
    Tian M; Nishijima Y; Asp ML; Stout MB; Reiser PJ; Belury MA
    Int J Oncol; 2010 Aug; 37(2):347-53. PubMed ID: 20596662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.
    Murphy KT; Chee A; Trieu J; Naim T; Lynch GS
    Int J Cancer; 2013 Sep; 133(5):1234-46. PubMed ID: 23436228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
    Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
    Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endurance training prevents TWEAK but not myostatin-mediated cardiac remodelling in cancer cachexia.
    Padrão AI; Moreira-Gonçalves D; Oliveira PA; Teixeira C; Faustino-Rocha AI; Helguero L; Vitorino R; Santos LL; Amado F; Duarte JA; Ferreira R
    Arch Biochem Biophys; 2015 Feb; 567():13-21. PubMed ID: 25575785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice.
    Tian M; Asp ML; Nishijima Y; Belury MA
    Int J Oncol; 2011 Nov; 39(5):1321-6. PubMed ID: 21822537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cytokines in cancer cachexia.
    Argilés JM; López-Soriano FJ
    Med Res Rev; 1999 May; 19(3):223-48. PubMed ID: 10232651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.
    Palus S; von Haehling S; Flach VC; Tschirner A; Doehner W; Anker SD; Springer J
    Int J Cardiol; 2013 Oct; 168(4):3412-8. PubMed ID: 23680591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome.
    Acharyya S; Guttridge DC
    Clin Cancer Res; 2007 Mar; 13(5):1356-61. PubMed ID: 17332276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardio-oncology - elucidation of the mechanism of cardiac dysfunction caused by cancer therapy and cancer cachexia].
    Nonaka M; Ueno S; Uezono Y
    Nihon Yakurigaku Zasshi; 2020; 155(3):165-170. PubMed ID: 32378637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmuscle Tissues Contribution to Cancer Cachexia.
    Argilés JM; Stemmler B; López-Soriano FJ; Busquets S
    Mediators Inflamm; 2015; 2015():182872. PubMed ID: 26523094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis and treatment of cardiac atrophy in cancer cachexia.
    Murphy KT
    Am J Physiol Heart Circ Physiol; 2016 Feb; 310(4):H466-77. PubMed ID: 26718971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cachexia and sarcopenia: mechanisms and potential targets for intervention.
    Argilés JM; Busquets S; Stemmler B; López-Soriano FJ
    Curr Opin Pharmacol; 2015 Jun; 22():100-6. PubMed ID: 25974750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Complications: The Understudied Aspect of Cancer Cachexia.
    Bora V; Patel B
    Cardiovasc Toxicol; 2022 Mar; 22(3):254-267. PubMed ID: 35171467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are tumoral factors responsible for host tissue wasting in cancer cachexia?
    Tisdale MJ
    Future Oncol; 2010 Apr; 6(4):503-13. PubMed ID: 20373865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
    Saitoh M; Ishida J; Doehner W; von Haehling S; Anker MS; Coats AJS; Anker SD; Springer J
    Int J Cardiol; 2017 Jul; 238():5-11. PubMed ID: 28427849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise Training as Therapy for Cancer-Induced Cardiac Cachexia.
    Antunes JMM; Ferreira RMP; Moreira-Gonçalves D
    Trends Mol Med; 2018 Aug; 24(8):709-727. PubMed ID: 29980479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.